Empirical Study on the Transparency of Security Risk Information in Chinese Listed Pharmaceutical Enterprises Based on the ANP-DS Method

Table 10

Distribution of data collection samples of listed pharmaceutical enterprises.

	Eastern China	Northeast China	North China	Central China	Southern China	Southwest China	Northwest China
Quantity	37	17	111	35	61	32	10
Proportion	0.122	0.056	0.366	0.116	0.201	0.106	0.033